Who Paid My Doc
Beth Hamann
Dentist Phoenix, AZ Doctor of Dentistry
NPI 1609875020 CMS profile 892736
4235 N 32Nd St, Suite C, Phoenix, AZ 85018
General payments
$1,925,191
Research payments
$0
Ownership & investment interest
$116,073,455
Through program year 2025, Beth Hamann of Phoenix, AZ is reported in the CMS Open Payments database as having received $1,925,191 across 30 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $116,073,455 across 21 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Dentist profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
14 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $370 | 9 | |
| 2024 | General | $689,165 | 6 | |
| 2023 | General | $427,900 | 2 | |
| 2022 | General | $475,039 | 3 | |
| 2021 | General | $237,538 | 3 | |
| 2020 | General | $29 | 2 | |
| 2019 | General | $95,150 | 5 | |
| 2025 | Ownership | $18,083,216 | 3 | |
| 2024 | Ownership | $16,458,602 | 3 | |
| 2023 | Ownership | $14,372,337 | 3 | |
| 2022 | Ownership | $16,232,458 | 3 | |
| 2021 | Ownership | $18,486,436 | 3 | |
| 2020 | Ownership | $16,331,041 | 3 | |
| 2019 | Ownership | $16,109,365 | 3 |
Beside peers
- Beth Hamann
- Dentist median
- Middle half of Dentist
- National median
In program year 2025, general payments to Beth Hamann were reported at $370. Among 32,838 Dentist profiles paid that year, the median was $70 and the middle half received between $27 and $192.
Show as a table
| Year | Beth Hamann | Dentist median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $95,150 | $62 | $24–$164 | $163 |
| 2020 | $29 | $73 | $24–$150 | $114 |
| 2021 | $237,538 | $72 | $24–$186 | $132 |
| 2022 | $475,039 | $73 | $26–$196 | $149 |
| 2023 | $427,900 | $75 | $28–$200 | $160 |
| 2024 | $689,165 | $73 | $27–$186 | $164 |
| 2025 | $370 | $70 | $27–$192 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 2 billing codesPaid by Medicare
$5,652
Medicare patients
71
Services billed
71
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 63% | |
| Arthritis | 48% | |
| Chronic kidney disease | 27% | |
| Depression | 27% | |
| Ischemic heart disease | 25% | |
| Diabetes | 24% | |
| Cancer | 23% | |
| Osteoporosis | 17% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
30 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist in Arizona
Related records
Dentist in Arizona
Practitioners in the same specialty and state, ranked by reported value.
All Dentist
Everyone recorded under this specialty, nationwide.
Doctors in Arizona
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.